Exploring the Shift in Aesthetic Trends: The Rise of Anti-Sagging Solutions in Medical Aesthetics

The landscape of medical aesthetics is evolving significantly, with a noticeable pivot towards the 'Anti-Sagging’ approach. This trend prioritizes the root factors contributing to skin laxity, moving beyond traditional treatments that mainly address visible signs of aging, such as wrinkles and volume loss. Instead of merely focusing on surface-level enhancements, the industry now emphasizes underlying structural issues that result from collagen depletion and compromised skin support systems.

A significant shift is underway as aesthetic practices transition from reliance on short-term solutions like Hyaluronic Acid (HA) fillers and botulinum toxins. The spotlight is now on innovative biostimulators designed to promote neocollagenesis, or the creation of new collagen. Among these pioneering products, the biodegradable polymer Polycaprolactone (PCL) stands out for its structural efficacy in fortifying the skin's foundation, correlating seamlessly with the Anti-Sagging movement.

One of the notable products making waves in this space is 'GOURI', a liquid PCL collagen stimulator developed by DEXLEVO. What sets GOURI apart is its unique formulation, which employs proprietary CESABP (Collagenesis-Enabled Solubilized Active and Biodegradable Polymer) technology, ensuring a microparticle-free experience. This characteristic allows for impressive spreadability upon injection, facilitating uniform collagen regeneration and enhancements in dermal elasticity across the entire face.

Unlike traditional particle-based fillers that localize their effects to the injection site, GOURI's formulation enables a holistic improvement to skin quality. At the recent IMCAS World Congress 2026 in Paris, Dr. Seung-min Oh showcased compelling clinical evidence regarding GOURI’s efficacy, highlighting three key benefits: reduced redness, enhanced skin texture, and increased volume. His presentations also emphasized precision in injection techniques utilizing detailed facial anatomy, further underscoring the potential of GOURI in achieving natural-looking results.

Dr. Oh, who holds the position of Chief Director at O Clinic and serves as the Academic Chair of the Korean Association of Laser, Dermatology, and Trichology, articulated the transformative potential of GOURI. He stated, "The unique spreadability of GOURI allows for natural collagen regeneration throughout the face. By leveraging this property with a thorough understanding of anatomical structures, we aim to provide patients with the most organic and healthy outcomes. It is essential that 'Precision Aesthetics', grounded in clinical evidence, becomes a standard across the industry.”

In essence, DEXLEVO continues to lead in the innovation of medical aesthetic solutions, laying down a clinical framework for combating skin laxity through cutting-edge Anti-Sagging products like GOURI. As the market adapts to these advancements, it will be fascinating to observe how they reshape patient expectations and industry standards. With a shift towards treatments that prioritize long-term skin health, the future of medical aesthetics looks promising indeed.

Conclusion

The development of PCL-based solutions like GOURI marks a significant step forward in understanding and addressing the complexities of skin aging. As practitioners and patients alike gain deeper insights into the mechanisms underlying aesthetic procedures, we can expect a paradigm shift that fundamentally alters how we approach cosmetic treatments. With an emphasis on structural integrity and a commitment to natural results, the Anti-Sagging trend could redefine the landscape of medical aesthetics for years to come.